Gene · 8744
Papers3,166
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,061 to 1,080 of 3,166
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| iPSC-Derived Natural Killer Cell Therapies - Expansion and Targeting. | Front Immunol | 2022 | 35185932 | PubTator, text mining | PubMed |
| Gnawing Between Cells and Cells in the Immune System: Friend or Foe? A Review of Trogocytosis. | Front Immunol | 2022 | 35185886 | PubTator, text mining | PubMed |
| Identification of Tumor Antigens and Immune Subtypes of Glioblastoma for mRNA Vaccine Development. | Front Immunol | 2022 | 35185876 | PubTator, text mining | PubMed |
| Unraveling the Expression Patterns of Immune Checkpoints Identifies New Subtypes and Emerging Therapeutic Indicators in Lung Adenocarcinoma. | Oxid Med Cell Longev | 2022 | 35178154 | PubTator, text mining | PubMed |
| Preclinical Characterization and Phase I Trial Results of a Bispecific Antibody Targeting PD-L1 and 4-1BB (GEN1046) in Patients with Advanced Refractory Solid Tumors. | Cancer Discov | 2022 | 35176764 | PubTator, text mining | PubMed |
| CD137L-macrophage induce lymphatic endothelial cells autophagy to promote lymphangiogenesis in renal fibrosis. | Int J Biol Sci | 2022 | 35173546 | PubTator, text mining | PubMed |
| CD19-directed chimeric antigen receptor T cell therapy in Waldenström macroglobulinemia: a preclinical model and initial clinical experience. | J Immunother Cancer | 2022 | 35173030 | PubTator, text mining | PubMed |
| Tumor-Derived Exosomes in Tumor-Induced Immune Suppression. | Int J Mol Sci | 2022 | 35163380 | PubTator, text mining | PubMed |
| Novel Cellular Therapies for Hepatocellular Carcinoma. | Cancers (Basel) | 2022 | 35158772 | PubTator, text mining | PubMed |
| Stereotactic Body Radiotherapy Immunological Planning-A Review With a Proposed Theoretical Model. | Front Oncol | 2022 | 35155221 | PubTator, text mining | PubMed |
| Three-dimensional colon cancer organoids model the response to CEA-CD3 T-cell engagers. | Theranostics | 2022 | 35154495 | PubTator, text mining | PubMed |
| System Analysis of Adaptor-Related Protein Complex 1 Subunit Mu 2 (AP1M2) on Malignant Tumors: A Pan-Cancer Analysis. | J Oncol | 2022 | 35154321 | PubTator, text mining | PubMed |
| PiggyBac Transposon-Mediated CD19 Chimeric Antigen Receptor-T Cells Derived From CD45RA-Positive Peripheral Blood Mononuclear Cells Possess Potent and Sustained Antileukemic Function. | Front Immunol | 2022 | 35154098 | PubTator, text mining | PubMed |
| The current state of knowledge of the immune ecosystem in alopecia areata. | Autoimmun Rev | 2022 | 35151885 | PubTator, text mining | PubMed |
| Molecular basis of the association between transcription regulators nuclear respiratory factor 1 and inhibitor of DNA binding protein 3 and the development of microvascular lesions. | Microvasc Res | 2022 | 35143811 | PubTator, text mining | PubMed |
| Immune priming using DC- and T cell-targeting gene therapy sensitizes both treated and distant B16 tumors to checkpoint inhibition. | Mol Ther Oncolytics | 2022 | 35141399 | PubTator, text mining | PubMed |
| 4-1BBL-containing leukemic extracellular vesicles promote immunosuppressive effector regulatory T cells. | Blood Adv | 2022 | 35130345 | PubTator, text mining | PubMed |
| The PD-L1/4-1BB Bispecific Antibody-Anticalin Fusion Protein PRS-344/S095012 Elicits Strong T-Cell Stimulation in a Tumor-Localized Manner. | Clin Cancer Res | 2022 | 35121624 | PubTator, text mining | PubMed |
| Inherited immunodeficiencies associated with proximal and distal defects in T cell receptor signaling and co-signaling. | Biomed J | 2022 | 35091087 | PubTator, text mining | PubMed |
| Fc-based Duokines: dual-acting costimulatory molecules comprising TNFSF ligands in the single-chain format fused to a heterodimerizing Fc (scDk-Fc). | Oncoimmunology | 2022 | 35083097 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8744/papers?page=54